Fecal Carriage of Carbapenemase and AmpC-β-lactamase Producers Among Extended Spectrum β-Lactamase-producing E. Coli and Klebsiella Spp. Isolates in Patients Attending Hospitals

Overview

Journal BMC Infect Dis

Publisher Biomed Central

Date 2025 Jan 24

PMID 39849346

Authors

Zakaria Garba

Isidore J O Bonkoungou

Namwin Siourime Somda

Magloire H Natama

Georges Some

Lassana Sangare

Nicolas Barro

Halidou Tinto

Affiliations

Soon will be listed here.

Abstract

Background: Extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE), particularly Escherichia coli and Klebsiella pneumoniae, have been consistently associated with treatment failure, high mortality and morbidity. The emergence of carbapenem resistance among ESBL-PE strains exacerbates the antimicrobial resistance. However, data are very limited in developing countries as Burkina Faso. This study aimed to determine the prevalence of carbapenemase and AmpC-β-lactamase production among ESBL-producing E. coli (ESBL-Ec) and Klebsiella spp. (ESBL-K) isolated from patients' stool in Burkina Faso.

Materials And Methods: From January 2020 to June 2022, we isolated 277 ESBL-PE from patients' stool in five hospitals in Burkina Faso. The strains were isolated on ESBL-selective chromogenic media and identified using API20E. The isolates were tested against 15 antimicrobial agents using the disc-diffusion method on Mueller-Hinton (MH) agar. ESBL production was confirmed by double disc synergy method. Carbapenemase and AmpC-β-lactamase production and phenotypic co-resistance were determined.

Results: Among the 277 ESBL-PE strains isolated, 203 were E. coli, and 74 were Klebsiella spp. Of these bacteria, 2.9% were carbapenemase producers and 6.5% were AmpC-β-lactamase producers. The carbapenemase producers were detected at tertiary and secondary hospitals, mainly in hospitalized patients and females, whereas AmpC-β-lactamase producers were detected at all levels of healthcare, predominantly in non-hospitalized patients, male, and under 15 years of age. The co-resistance rates were as high as 82% for fluoroquinolones, 91% for aminoglycosides, and 94% for sulfonamides. Fosfomycin resistance was 2.5% for ESBL-Ec and 50% for ESBL-K.

Conclusion: This study showed that ESBL-PEs co-produce carbapenemase and/or AmpC-β-lactamase. High co-resistances were reported for commonly used antibiotic agents. Therefore, screening for carbapenem-resistant Enterobacterales (CRE) carriage is necessary to limit its spread within hospitals.

References

Rodriguez-Bano J, Gutierrez-Gutierrez B, Machuca I, Pascual A . Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clin Microbiol Rev. 2018; 31(2). PMC: 5967687. DOI: 10.1128/CMR.00079-17. View

Dikoumba A, Onanga R, Jean-Pierre H, Didelot M, Dumont Y, Ouedraogo A . Prevalence and Phenotypic and Molecular Characterization of Carbapenemase-Producing Gram-Negative Bacteria in Gabon. Am J Trop Med Hyg. 2022; 108(2):268-274. PMC: 9896342. DOI: 10.4269/ajtmh.22-0168. View

Ouchar Mahamat O, Tidjani A, Lounnas M, Hide M, Benavides J, Somasse C . Fecal carriage of extended-spectrum β-lactamase-producing in hospital and community settings in Chad. Antimicrob Resist Infect Control. 2019; 8:169. PMC: 6824111. DOI: 10.1186/s13756-019-0626-z. View

Mudenda S, Mulenga K, Nyirongo R, Chabalenge B, Chileshe C, Daka V . Non-prescription sale and dispensing of antibiotics for prophylaxis in broiler chickens in Lusaka District, Zambia: findings and implications on one health. JAC Antimicrob Resist. 2024; 6(3):dlae094. PMC: 11166086. DOI: 10.1093/jacamr/dlae094. View

Burow E, Simoneit C, Tenhagen B, Kasbohrer A . Oral antimicrobials increase antimicrobial resistance in porcine E. coli--a systematic review. Prev Vet Med. 2014; 113(4):364-75. DOI: 10.1016/j.prevetmed.2013.12.007. View

Shinu P, Bareja R, Nair A, Mishra V, Hussain S, Venugopala K . Monitoring of Non-β-Lactam Antibiotic Resistance-Associated Genes in ESBL Producing Isolates. Antibiotics (Basel). 2020; 9(12). PMC: 7764327. DOI: 10.3390/antibiotics9120884. View

Sanneh B, Kebbeh A, Jallow H, Camara Y, Mwamakamba L, Ceesay I . Prevalence and risk factors for faecal carriage of Extended Spectrum β-lactamase producing Enterobacteriaceae among food handlers in lower basic schools in West Coast Region of The Gambia. PLoS One. 2018; 13(8):e0200894. PMC: 6089431. DOI: 10.1371/journal.pone.0200894. View

Manenzhe R, Zar H, Nicol M, Kaba M . The spread of carbapenemase-producing bacteria in Africa: a systematic review. J Antimicrob Chemother. 2014; 70(1):23-40. PMC: 5975721. DOI: 10.1093/jac/dku356. View

Morrill H, Pogue J, Kaye K, LaPlante K . Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections. Open Forum Infect Dis. 2015; 2(2):ofv050. PMC: 4462593. DOI: 10.1093/ofid/ofv050. View

10.

Bezabih Y, Sabiiti W, Alamneh E, Bezabih A, Peterson G, Bezabhe W . The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community. J Antimicrob Chemother. 2020; 76(1):22-29. DOI: 10.1093/jac/dkaa399. View

11.

Abdallah H, Alnaiemi N, Reuland E, Wintermans B, Koek A, Abdelwahab A . Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study. Antimicrob Resist Infect Control. 2017; 6:62. PMC: 5470242. DOI: 10.1186/s13756-017-0219-7. View

12.

Arhoune B, Oumokhtar B, Hmami F, Barguigua A, Timinouni M, El Fakir S . Rectal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae among hospitalised neonates in a neonatal intensive care unit in Fez, Morocco. J Glob Antimicrob Resist. 2017; 8:90-96. DOI: 10.1016/j.jgar.2016.11.004. View

13.

Bain R, Cronk R, Wright J, Yang H, Slaymaker T, Bartram J . Fecal contamination of drinking-water in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med. 2014; 11(5):e1001644. PMC: 4011876. DOI: 10.1371/journal.pmed.1001644. View

14.

Mahato S, Mahato A, Pokharel E, Tamrakar A . Detection of extended-spectrum beta-lactamase-producing E. coli and Klebsiella spp. in effluents of different hospitals sewage in Biratnagar, Nepal. BMC Res Notes. 2019; 12(1):641. PMC: 6778374. DOI: 10.1186/s13104-019-4689-y. View

14.

Lepape A, Jean A, De Waele J, Friggeri A, Savey A, Vanhems P . European intensive care physicians' experience of infections due to antibiotic-resistant bacteria. Antimicrob Resist Infect Control. 2020; 9(1):1. PMC: 6941296. DOI: 10.1186/s13756-019-0662-8. View

15.

Alevizakos M, Karanika S, Detsis M, Mylonakis E . Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. Int J Antimicrob Agents. 2016; 48(6):647-654. DOI: 10.1016/j.ijantimicag.2016.08.021. View

16.

Stoesser N, Xayaheuang S, Vongsouvath M, Phommasone K, Elliott I, Del Ojo Elias C . Colonization with Enterobacteriaceae producing ESBLs in children attending pre-school childcare facilities in the Lao People's Democratic Republic. J Antimicrob Chemother. 2015; 70(6):1893-7. PMC: 4498295. DOI: 10.1093/jac/dkv021. View

17.

Kagambega A, Dembele R, Bientz L, Mzali F, Mayonnove L, Mohamed A . Detection and Characterization of Carbapenemase-Producing and from Hospital Effluents of Ouagadougou, Burkina Faso. Antibiotics (Basel). 2023; 12(10). PMC: 10603891. DOI: 10.3390/antibiotics12101494. View

18.

Biehl L, Schmidt-Hieber M, Liss B, Cornely O, Vehreschild M . Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective. Crit Rev Microbiol. 2014; 42(1):1-16. DOI: 10.3109/1040841X.2013.875515. View

19.

Chaoui L, Mhand R, Mellouki F, Rhallabi N . Contamination of the Surfaces of a Health Care Environment by Multidrug-Resistant (MDR) Bacteria. Int J Microbiol. 2019; 2019:3236526. PMC: 6906863. DOI: 10.1155/2019/3236526. View